Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Focus Diagnostics developed and commercialized several FDA-cleared molecular and serology-based diagnostic tests. Its Simplexa™ platform was among the first to receive FDA clearance for H1N1 detection in 2010. The company’s products have won industry awards for innovation. It operated ISO 9001-certified manufacturing facilities and reference labs. In 2016, DiaSorin acquired its molecular and immunoassay product business from Quest Diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Focus Diagnostics.